Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Testing Machines Inc. on acquisition of Fibro System AB
Mandate

Vinge advises Testing Machines Inc. on acquisition of Fibro System AB

January 20, 2012

Vinge advises Testing Machines Inc. (TMI) in connection with the acquisition of Fibro System AB. Fibro System develops, manufactures and sell measurement technology equipment for the pulp and paper, print, packaging and other related industries. TMI manufactures and markets physical property testing instruments for the paper, pulp, film, foil, ink, coatings, nonwoven, textile and corrugated industries. TMI has a network of sales offices and agents throughout the US and in over 50 countries.

The Vinge team advising TMI includes partner Malin Ohlin Åkermark and associates Peter Sundgren and Nina Farrahi (M&A), associate Albert Wållgren (banking & finance) and associate Karin Isacson (employment & benefits).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026